a Department of Chemistry , Isfahan University of Technology , Isfahan , Iran.
J Biomol Struct Dyn. 2018 May;36(7):1822-1833. doi: 10.1080/07391102.2017.1335618. Epub 2017 Jun 14.
Peroxisome proliferator-activated receptors (PPARs) compose a family of nuclear receptors, PPARα, PPARβ, and PPARγ, which mediate the effects of lipidic ligands at the transcriptional level. Among these, the PPARγ has been known to regulate adipocyte differentiation, fatty acid storage and glucose metabolism, and is a target of antidiabetic drugs. In this work, the interactions between PPARγ and its six known antagonists were investigated using computational methods such as molecular docking, molecular dynamics (MD) simulations, and the hybrid quantum mechanics/molecular mechanics (QM/MM). The binding energies evaluated by molecular docking varied between -22.59 and -35.15 kJ mol. In addition, MD simulations were performed to investigate the binding modes and PPARγ conformational changes upon binding of antagonists. Analysis of the root-mean-square fluctuations (RMSF) of backbone atoms shows that H3 of PPARγ has a higher mobility in the absence of antagonists and moderate conformational changes were observed. The interaction energies between antagonists and each PPARγ residue involved in the interactions were studied by QM/MM calculations. These calculations reveal that antagonists with different structures show different interaction energies with the same residue of PPARγ. Therefore, it can be concluded that the key residues vary depending on the structure of the ligand, which binds to PPARγ.
过氧化物酶体增殖物激活受体 (PPARs) 构成了核受体家族,包括 PPARα、PPARβ 和 PPARγ,它们在转录水平上介导脂质配体的作用。其中,PPARγ 已被证明可调节脂肪细胞分化、脂肪酸储存和葡萄糖代谢,是抗糖尿病药物的靶点。在这项工作中,使用分子对接、分子动力学 (MD) 模拟和混合量子力学/分子力学 (QM/MM) 等计算方法研究了 PPARγ 与其六个已知拮抗剂之间的相互作用。分子对接评估的结合能在 -22.59 到 -35.15 kJ/mol 之间变化。此外,还进行了 MD 模拟以研究拮抗剂结合时的结合模式和 PPARγ 构象变化。对骨架原子均方根波动 (RMSF) 的分析表明,在没有拮抗剂的情况下,PPARγ 的 H3 具有更高的迁移率,并且观察到中等程度的构象变化。通过 QM/MM 计算研究了拮抗剂与参与相互作用的每个 PPARγ 残基之间的相互作用能。这些计算表明,具有不同结构的拮抗剂与 PPARγ 相同残基的相互作用能不同。因此,可以得出结论,关键残基取决于与 PPARγ 结合的配体的结构。